Erzofri extended-release
paliperidone palmitate
- Strength
- 39 mg/.25mL
- Form
- Injection
- Class
- Atypical Antipsychotic
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Listed by Shandong Luye Pharmaceutical Co., Ltd.
| Dosage form | Injection |
|---|---|
| Route | Intramuscular |
| Drug class | Atypical Antipsychotic |
| Approval route | NDA — original brand approval |
| NDC code | 72526-107 |
| FDA application | NDA216352 |
| RxNorm concept | 858048 |
| Package sizes listed | 1 |
| Marketed since | December 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
paliperidone palmitate
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Shandong Luye Pharmaceutical Co., Ltd.
Not stocked by us — reference only
paliperidone palmitate
Janssen Pharmaceuticals, Inc
Not stocked by us — reference only
paliperidone palmitate
Janssen Pharmaceuticals, Inc
Not stocked by us — reference only
paliperidone palmitate
Janssen Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.